HDAX Therapeutics
PrivateLast Round
Seed
Sep 5, 2024
Total Funding Raised
$3.82M
Momentum Score
50 /100
Company Overview
HDAX Therapeutics is a biotechnology company developing small molecule therapeutics targeting HDAC6 for the treatment of neurological and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HDAX Therapeutics Comps
Public and private peers based on sector, stage, and business model.
HDAX Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2024 | ||||
| Grant | Jul 8, 2024 | ||||
| Grant | Oct 12, 2023 |
Key People
Founding team and executive leadership
HDAX Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Sciences Innovation Fund | Grant |
| SeedFolio | Seed |
| TIAP | Seed |
| FACIT | Seed |
| Ontario Centre of Innovation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Open roles tripled to 3, representing 21% of headcount.
HDAX Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HDAX Therapeutics's valuation, stock price, and market status.
